FY27 on track, but QoQ PAT decline and pending ITC merger cloud near term

Delivered ₹645.4Cr, 12.5% YoY—exactly on target

Claimed ₹119Cr profit, 18.5% margin. Delivered shows 18.2% OPM—30 bp shortfall. Adjusted PAT ₹79.1Cr vs reported ₹62.2Cr gap unexplained

Delivered 18.2%, not 18.5%. Sequential improvement real but margin ceiling lower than claimed

YoY +15.1% confirmed, but QoQ declined -8%—a red flag masked by YoY framing

ITC Infotech expected to close Oct-Nov 2027; current HM + ITC combined ~₹920-950Cr annualized. $1B needs flawless integration + 5-10% organic growth—not assured

August 31, 2026 deal transforms growth trajectory. $1B FY28 aspiration (vs prior 15% organic growth) contingent on integration success by Oct-Nov 2027

Q2 showed 0.9% US revenue growth; 6 quarters of $38-39M flatness. Management cited EdTech funding challenges, repositioning underway but not yet proven

12.5% FY27 growth reaffirmed by Q2 delivery; 15% FY28 organic aspiration not raised or cut. Merger aspiration ($1B) is additive, not a revision of base guidance

US geo grew 0.9% Q2. Bookings positive but EdTech 90% of our US EdTech revenue, facing funding challenges. Repositioning EdTech to ME/India/Southeast Asia. NN sales team reorganized (1.5yr focus).

Annuity-based deals with security focus driving spend increase. 3-4 good US annuity deals plus one large ME deal from conglomerate. Right-shifting from Q1 revenues also boosted Q2. Majority annuity-based.

ELLIPSE platform (AI-driven infrastructure monitoring) with 21 customers onboarded. SecAIGenie (AI security services) gaining traction. Rel(AI)Build framework (15 customers adopted).

Unallocable = corporate costs allocated till gross margin, then shown separately. Operating margin improved 17.5%→18.5% due to IP growth + utilization 81.8% (all-time high). Margin expansion real at company level.

ESOP scheme instituted last year; doing similar next year in consultation with ITC Infotech. ESOP incentivizes top leaders; will help retention.

Merger in steps: CCI approval, then NCLT approval (shareholders & creditors), then merger effectiveness. SPA tranche 1 = 11% transfer post-CCI; tranche 2 = 11% post-shareholder approval Feb-Mar 2027. Expected merged by October-November 2027.

Agents deployed in both customer business process workflows and our SDLC. Using Rel(AI)Build + Claude foundation models to create outcome-based models. Goal: price optimization, margin preservation, competitive advantage.

Top 5 diversified: health care, BFSI, EdTech, health care, EdTech. One EdTech customer from NN logos (NN=new sales team). Diversification good; EdTech risk being mitigated.

FY27 guidance set in Q1 call. Q2 on target. H1 at 13.4%, implying H2 slightly lower but within 12.5% range

Prior guidance carried forward. No explicit mention on this call, but consistent with 'sustaining growth' commentary

New deal (announced Aug 31). Contingent on merger close Oct-Nov 2027. Requires 5–10% annual organic growth + successful integration. Additive to base FY27/FY28 guidance

Within stated range. 30 bp gap between claim and delivery. Management attributes to IP/utilization but doesn't account for unallocable cost drag

ITC Infotech margins healthy at 18.4% on combined basis. Integration synergies (cost, scale) expected but not quantified. Execution risk on timeline

Focus on organic investment in AI platforms (Rel(AI)Build, ELLIPSE, SecAIGenie) and GCC expansion. Merger will likely require integration capex post-close

ITC Infotech merger expected Oct-Nov 2027. NCLT approval, shareholder approvals, and debt restructuring steps required. Combined ₹1,600+ Cr entity integration complexity high. Cost & revenue synergies quantified at $1B but execution risk material.

Americas (56% revenue) flat for 6 consecutive quarters at $38–39M. EdTech 90% of US EdTech revenue, facing funding winter. Management pivoting EdTech to ME/India but US primary market rebalancing unproven. Risk: further US deceleration could pressure overall growth targets.

Q2 PAT ₹62.2Cr declined -8% QoQ despite revenue +2.7% QoQ. Gap between adjusted (₹79.1Cr) and reported (₹62.2Cr) PAT of ₹16.9Cr not fully itemized. Suggests either integration costs, one-time charges, or wage inflation not yet offset by operational leverage. Risk: margin compression if cost inflation persists.

Generative AI business delivered ~135% H1 YoY growth but from small base. 55% of projects AI-enabled and 15 customers on Rel(AI)Build framework are early signals, not yet material revenue. Risk: if AI adoption slows or margins on AI services are lower, growth narrative loses traction.

95% of revenue from 95 billion-dollar corporations. While top 5 are being diversified, concentration remains. Risk: loss of a top-5 customer or macro pullback in customer capex spending could pressure growth.